Shopping Cart
Remove All
Your shopping cart is currently empty
RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (pIC50 value of 8) and effectively inhibits the release of TNF-α.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | Inquiry | Inquiry |
| Description | RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (pIC50 value of 8) and effectively inhibits the release of TNF-α. |
| Targets&IC50 | RIPK2:8 (pIC50) |
| In vitro | RIP2 Kinase Inhibitor 4 (Compound 20) is a novel inhibitor targeting the apoptosis (IAP) binder, with reduced binding to the cIAP1 and XIAP BIR3 domains but enhanced binding to the XIAP BIR2 domain[1]. Additionally, it recruits IAP E3 ligases and significantly reduces MDP-induced TNFα production in human PBMCs, with a pIC50 value of 9.3[1]. |
| In vivo | The initial in vivo evaluation of RIP2 Kinase Inhibitor 4 (Compound 20) in rats, administered subcutaneously at a dose of 0.5 mg/kg, showed significant degradation of RIPK2 and suppression of MDP-induced TNFα release after 48 hours[1]. |
| Molecular Weight | 1045.23 |
| Formula | C50H66F2N14O7S |
| Cas No. | 2126803-41-4 |
| Smiles | CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)Nc1c(F)cccc1F)NC(=O)c1cnc(cn1)N1CCN(CCCOc2cc3ncnc(Nc4n[nH]c(C)c4C)c3cc2S(=O)(=O)C(C)(C)C)CC1)C(C)(C)C |@@:70| |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.